Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine

19 Oct 2015

Abstract excerpt

In the 1800s, a baby born with a caul, a remnant of the amniotic sack or fetal membranes, was thought to be lucky, special, or protected. Over time, fetal membranes lost their legendary power and were soon considered nothing more than biological waste after birth. However, placenta tissues have reclaimed their potential and since the early 1900s an increasing body of evidence has shown that these tissues have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to Mesenchymal stem cell research
Share to Organ and Tissue Transplantation Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26539433
DOI: 10.3389/fbioe.2015.00162

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Long Path of Human Placenta, and Its Derivatives, in Regenerative MedicinePMID 26539433Read ↗

Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and ProspectsSemantic proximity Read ↗

The Placenta as an Organ and a Source of Stem Cells and Extracellular Matrix: A ReviewSemantic proximity Read ↗

Perinatal Derivatives: Where Do We Stand? A Roadmap of the Human Placenta and Consensus for Tissue and Cell NomenclatureSemantic proximity Read ↗

Exploring maternal-fetal interface with in vitro placental and trophoblastic modelsSemantic proximity Read ↗

Toward Cell Therapy Using Placenta-Derived Cells: Disease Mechanisms, Cell Biology, Preclinical Studies, and Regulatory Aspects at the Round TableSemantic proximity Read ↗

Placenta as a reservoir of stem cells: an underutilized resource?Semantic proximity Read ↗

Modelling the Human Placental Interface In Vitro—A ReviewSemantic proximity Read ↗

Ethical considerations for advancing research using organoid models derived from the placentaSemantic proximity Read ↗

Isolation of Multipotent Cells from Human Term PlacentaSemantic proximity Read ↗

Mesenchymal Stem/Stromal Cells Derived from Human and Animal Perinatal Tissues—Origins, Characteristics, Signaling Pathways, and Clinical TrialsSemantic proximity Read ↗

How far are we from the clinical use of placental-derived mesenchymal stem cells?Semantic proximity Read ↗

Engineering placenta‐like organoids containing endogenous vascular cells from human‐induced pluripotent stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.